Approval · Notice of Compliance 17277 · 2015
TACTUPUMP PLUS: Notice of Compliance 17277
Issued September 16, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17277
- Date
- September 16, 2015
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add new strength and expand the indication for tactupump plus
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TACTUPUMP PLUS | 02446235 | Marketed |
Medicinal ingredients
- BENZOYL PEROXIDE 25 MG per G
- ADAPALENE 3 MG per G